LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

30.68 4.35

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

28.86

Max

31.83

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-14M -81M
Pardavimai	75K 75K
Pelnas, tenkantis vienai akcijai	-1.22
Pelno marža	-108,422.667
Darbuotojai	186
EBITDA	-7.8M -81M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+86.54% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-06

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	377M 2B
Ankstesnė atidarymo kaina	26.33
Ankstesnė uždarymo kaina	30.68

Naujienos nuotaikos

By Acuity

50%

145 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-09 18:13; UTC

Įsigijimai, susijungimai, perėmimai

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

2026-03-09 17:20; UTC

Svarbiausios naujienos

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

2026-03-09 17:15; UTC

Įsigijimai, susijungimai, perėmimai

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

2026-03-10 00:00; UTC

Svarbiausios naujienos

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

2026-03-09 23:52; UTC

Rinkos pokalbiai

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

2026-03-09 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

2026-03-09 23:50; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-09 23:46; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Correction to Crude Prices Market Talk on March 9

2026-03-09 23:42; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

2026-03-09 23:08; UTC

Svarbiausios naujienos

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

2026-03-09 23:07; UTC

Svarbiausios naujienos

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

2026-03-09 21:29; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue Now Fully Owns Peru's Canariaco Copper Project

2026-03-09 21:28; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue Completes Acquisition of Remaining Alta Copper Shares

2026-03-09 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-03-09 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-09 20:47; UTC

Svarbiausios naujienos

The 24 Hours When Oil Markets Went Wild -- WSJ

2026-03-09 20:33; UTC

Svarbiausios naujienos

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

2026-03-09 20:14; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

2026-03-09 19:33; UTC

Svarbiausios naujienos

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

2026-03-09 19:17; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

2026-03-09 19:14; UTC

Rinkos pokalbiai

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

2026-03-09 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2026-03-09 18:23; UTC

Rinkos pokalbiai

Svarbiausios naujienos

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

2026-03-09 17:58; UTC

Įsigijimai, susijungimai, perėmimai

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

2026-03-09 17:57; UTC

Įsigijimai, susijungimai, perėmimai

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

2026-03-09 17:41; UTC

Svarbiausios naujienos

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

2026-03-09 17:41; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

2026-03-09 17:08; UTC

Rinkos pokalbiai

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

2026-03-09 17:04; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-09 17:04; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

86.54% į viršų

12 mėnesių prognozė

Vidutinis 54.9 USD 86.54%

Aukščiausias 90 USD

Žemiausias 24 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

Pirkti

Laikyti

Parduoti

Remiantis 11 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

145 / 351 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.